Pulmonale Hypertonie

Die pulmonale Hypertonie ist keineswegs eine seltene Erkrankung. Sie besteht definitionsgemäß bei

• einem mittleren pulmonalarteriellen Druck ≥ 25 mmHg,

• pulmonalarteriellem Verschlussdruck ≤ 15 mmHg und

• pulmonalem Gefäßwiderstand > 3 Wood-Einheiten in Ruhe [1].

• Literatur

• 1 Hoeper MM, Ghofrani HA, Grünig E. et al. Pulmonary Hypertension. Dtsch Arztebl Int 2017; 114: 73-84
• 2 Ahmed A, Akintoye E, Adegbala O. et al. In-hospital outcomes of transcatheter mitral valve repair with Mitraclip in patients with pulmonary hypertension: Insights from the National Inpatient Sample. Catheter Cardiovasc Interv 2018;
• 3 Pilkington SA, Taboada D, Martinez G. Pulmonary hypertension and its management in patients undergoing non-cardiac surgery. Anaesthesia 2015; 70: 56-70
• 4 Meyer S, McLaughlin VV, Seyfarth HJ. et al. Outcomes of noncardiac, nonobstetric surgery in patients with PAH: an international prospective survey. Eur Respir J 2013; 41: 1302-1307
• 5 Ramakrishna G, Sprung J, Ravi BS. et al. Impact of pulmonary hypertension on the outcomes of non-cardiac surgery: predictors of perioperative morbidity and mortality. J Am Coll Cardiol 2005; 45: 1691-1699
• 6 Shah AC, Ma K, Faraoni D. et al. Self-reported functional status predicts post-operative outcomes in non-cardiac surgery patients with pulmonary hypertension. PLoS One 2018; 13: e0201914